Want to see HK:0928 full AI Analyst Report?
0928 Stock Chart & Stats
HK$0.11
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.11
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.06 - HK$0.15
Previous CloseN/A
Volume420.00K
Average Volume (3M)760.77K
Market Cap
HK$186.89M
Enterprise ValueHK$212.85
Total Cash (Recent Filing)HK$591.00K
Total Debt (Recent Filing)HK$2.11M
Price to Earnings (P/E)101.0
Beta0.78
Next Earnings
Nov 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding1,850,425,000
10 Day Avg. Volume724,000
30 Day Avg. Volume760,773
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.24
Price to Sales (P/S)1.32
P/FCF Ratio-166.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial StabilityA strong equity ratio and low debt-to-equity ratio suggest that the company is financially stable, providing a solid foundation for future growth and resilience against economic fluctuations.
Strategic PartnershipsThe strategic partnership with Mingyuan aims to enhance market penetration and brand value in Mainland China, potentially leading to increased revenue and competitive positioning over the long term.
Board RestructuringThe restructuring of the board and establishment of committees can enhance governance and operational oversight, potentially improving decision-making and strategic direction.
Bears Say
Compliance ChallengesNon-compliance with listing rules due to board changes may affect investor confidence and require swift action to restore compliance, impacting the company's governance reputation.
Legal DisputesOngoing legal disputes related to unauthorized agreements could lead to financial losses and distract management, potentially affecting the company's operational focus and reputation.
Cash Flow ChallengesPersistent negative cash flows indicate challenges in converting earnings into cash, which could impact the company's ability to invest in growth opportunities and meet financial obligations.
Life Healthcare Group News
0928 FAQ
What was Life Healthcare Group Limited’s price range in the past 12 months?
Life Healthcare Group Limited lowest stock price was HK$0.06 and its highest was HK$0.15 in the past 12 months.
What is Life Healthcare Group Limited’s market cap?
Life Healthcare Group Limited’s market cap is HK$186.89M.
When is Life Healthcare Group Limited’s upcoming earnings report date?
Life Healthcare Group Limited’s upcoming earnings report date is Nov 27, 2026 which is in 115 days.
How were Life Healthcare Group Limited’s earnings last quarter?
Life Healthcare Group Limited released its earnings results on Jun 30, 2026. The company reported -HK$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Life Healthcare Group Limited overvalued?
According to Wall Street analysts Life Healthcare Group Limited’s price is currently Overvalued.
Does Life Healthcare Group Limited pay dividends?
Life Healthcare Group Limited does not currently pay dividends.
What is Life Healthcare Group Limited’s EPS estimate?
Life Healthcare Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Life Healthcare Group Limited have?
Life Healthcare Group Limited has 1,850,425,000 shares outstanding.
What happened to Life Healthcare Group Limited’s price movement after its last earnings report?
Life Healthcare Group Limited reported an EPS of -HK$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.493%.
Which hedge fund is a major shareholder of Life Healthcare Group Limited?
Currently, no hedge funds are holding shares in HK:0928
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Life Healthcare Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
81.25%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
34.50%
Trailing 12-Months
Company Description
Life Healthcare Group Limited
King International Investment Limited operates as a holding company, with its core activities focused on the provision of healthcare products and related services. The firm's business interests are diversified, also encompassing money lending and the distribution of alcoholic beverages. Its geographical reach extends across both mainland China and Hong Kong. Established on March 12, 2001, the company maintains its headquarters in Hong Kong.
Technical Analysis
Perfect Medical Health Management Limited
―
EC Healthcare
―
Yestar Healthcare Holdings Co Ltd
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―